TY - CHAP M1 - Book, Section TI - Hypersensitivity Syndromes and Drug Reactions A1 - Usatine, Richard P. A1 - Sabella, Camille A1 - Smith, Mindy Ann A1 - Mayeaux, E.J. A1 - Chumley, Heidi S. A1 - Appachi, Elumalai PY - 2015 T2 - The Color Atlas of Pediatrics AB - References1Shaw JC. Erythema multiforme. In: Noble J Green H Levinson W et al, eds. Textbook of Primary Care Medicine 3rd ed. St. Louis, MO: Mosby; 2001:815–816.2Tan SK Tay YK. Profile and Pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes. Acta Derm Venereol. 2012;92(1):62–66.21710108[PubMed: ]3Finkelstein Y Soon GS Acuna P et al. Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Pediatrics. 2011;128(4):723–728.21890829[PubMed: ]4Del Pozzo-Magana BR Lazo-Langner A Carleton B. A systematic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children. J Popul Ther Clin Pharmacol. 2011;18:e121–e133.21467603[PubMed: ]5Plaza JA. Erythema Multiforme. Updated July 29, 2011. http://emedicine.medscape.com/article/1122915-overview, accessed January 2012.6Darmstadt GL. Erythema multiforme. In: Long S Pickering L Prober C, eds. Principles and Practice of Pediatric Infectious Diseases 2nd ed. New York, NY: Churchill Livingstone; 2003:442–444.7Morelli JG. Vesiculobullous disorders. In: Behrman R Kliegman RM Jenson HB, eds. Nelson Textbook of Pediatrics 19th ed. Philadelphia, PA: Saunders; 2011:2241–2249.8Weston WL. Herpes associated erythema multiforme. J Invest Dermatol. 2005;124(6):xv–xvi.15999399[PubMed: ]9Sanmarkan AD Tukaram S Thappa DM et al. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis over a period of 10 years. Indian J Dermatol. 2011;56(1):25–29.21572786[PubMed: ]10Newburger JW Takahashi M Gerber MA et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004;110(17):2747–2771.15505111[PubMed: ]11Worswick S Cotliar J. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options. Dermatol Ther. 2011;24(2):207–218.21410610[PubMed: ]12Bastuji-Garin S Fouchard N Bertocchi M et al. SCORTEN: a severity of illness score for toxic epidermal necrolysis. J Invest Dermatol. 2000;115(2):149–153.10951229[PubMed: ] SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accesspediatrics.mhmedical.com/content.aspx?aid=1114876992 ER -